Ticrynafen: Kinetics, protein binding, and effects on serum and urinary uric acid
Ticrynafen: Kinetics, protein binding, and effects on serum and urinary uric acid
复制标题
Ticrynafen:动力学、蛋白质结合以及对血清和尿尿酸的影响
DOI:
10.1002/cpt1978236697
复制
发表时间:
1978
影响因子:
6.7
通讯作者:
F. O. Simpson
中科院分区:
文献类型:
--
作者:
A. Wood;P. Bolli;H. Waal‐Manning;F. O. Simpson
The kinetics and acute effects of ticrynafen, a new diuretic and uricosuric, have been studied in 4 normal subjects. In 3 of the 4 subjects given a 250‐mg tablet, peak plasma ticrynafen concentrations of 15 to 35 µg/ml were achieved at 1 to 2 hr; in the fourth subject a peak concentration of 10 µg/ml was attained at 6 hr. Elimination half‐life was 2.0 to 3.3 hr. Bioavailability covered a 2.5‐fold range (61.7–154.6 µg · hr · ml−1). Administration of the same dose as quarter doses at 2 hr intervals produced a progressive rise in plasma ticrynafen concentration to 5.5 to 12.9 µg/ml at 8 hr and thereafter a decline at a similar rate to that seen with the single dose. The hypouricemic effect was similar for the single‐ and divided‐dose treatments: uric acid concentration began to fall within 1 hr, reached a minimum of 53% to 77% of the pre‐drug value at 7 to 10 hr, and had returned to approximately pre‐drug values at 24 hr. Urinary uric acid excretion was significantly increased for up to 12 hr with both treatments. The diuretic effect of the single dose lasted 4 to 8 hr, while that of the divided dose lasted 8 to 12 hr.